TipRanks
Entrada Therapeutics Inc (TRDA)
NASDAQ:TRDA
US Market
TRDA
Entrada Therapeutics Inc
RESEARCH TOOLSreports
Want to see TRDA full AI Analyst Report?

Entrada Therapeutics Inc (TRDA) Stock News & Sentiment

164 Followers
Entrada Therapeutics Stockholders Approve Directors and Equity Plans
Premium
Company Announcements
Entrada Therapeutics Stockholders Approve Directors and Equity Plans
4M ago
8K
TRDA
Entrada Therapeutics Highlights Transformational Year and Pipeline Progress
Premium
Company Announcements
Entrada Therapeutics Highlights Transformational Year and Pipeline Progress
5M ago
8K
TRDA
Buy Rating Reaffirmed on TRDA as ENTR‑601‑44 Shows Clinically Meaningful Functional Gains and Higher-Dose Data Loom as Key Catalyst
Premium
Ratings
Buy Rating Reaffirmed on TRDA as ENTR‑601‑44 Shows Clinically Meaningful Functional Gains and Higher-Dose Data Loom as Key Catalyst
5M ago
TRDA
Entrada posts strong ENTR-601-44 Duchenne Phase 1/2 data
Premium
Company Announcements
Entrada posts strong ENTR-601-44 Duchenne Phase 1/2 data
5M ago
8K
TRDA
Advancing Exon-Skipping and Undervalued DM1 Collaboration Underscore Buy Rating on Entrada Therapeutics
Premium
Ratings
Advancing Exon-Skipping and Undervalued DM1 Collaboration Underscore Buy Rating on Entrada Therapeutics
7M ago
TRDA
Advancing DMD and DM1 Pipeline Positions Entrada for Multiple Near‑Term Catalysts and Upside Potential
Premium
Ratings
Advancing DMD and DM1 Pipeline Positions Entrada for Multiple Near‑Term Catalysts and Upside Potential
8M ago
TRDA
Entrada Therapeutics: Advancing ENTR-601-44 Positions Platform for Best-in-Class Dystrophin Restoration and Attractive Risk/Reward
Premium
Ratings
Entrada Therapeutics: Advancing ENTR-601-44 Positions Platform for Best-in-Class Dystrophin Restoration and Attractive Risk/Reward
8M ago
TRDA
More TRDA News >

TRDA News on the Web

Major Investors Quietly Unload a Big Chunk of Entrada Therapeutics Shares
TipRanks News
Neutral
Major Investors Quietly Unload a Big Chunk of Entrada Therapeutics Stock
TipRanks News
Neutral
Major Investors Quietly Unload Big Chunk of Entrada Therapeutics Stock
TipRanks News
Neutral
Major Insider Moves Shake Up Entrada Therapeutics Inc. Stock
TipRanks News
Neutral
Entrada Q2 Loss Shrinks; Data From Phase 1/2 Trials In DMD And DM1 Expected In '27
rttnews
Bullish
Entrada Therapeutics Stockholders Approve Directors and Equity Plans
TipRanks News
Neutral
Entrada Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript
GuruFocus News
Neutral
Analysts Have Conflicting Sentiments on These Healthcare Companies: Entrada Therapeutics Inc (TRDA) and Pfizer (PFE)
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average1 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TRDA’s Media Buzz Sentiment?
Currently, no data Available
What is TRDA’s weekly average amount of articles?
In an average week, 1 articles about TRDA are published.
    What is TRDA’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    HUMHumana
    ACETAdicet Bio
    ZYMEZymeworks
    RHHBYRoche Holding
    QTTBQ32 Bio
    Showing the stocks with the most bullish news sentiment over the past week